[Antiviral agents for reduction of mother-to-child transmission of HIV infection].
Bruun
Johan N
JN
Infeksjonsmedisinsk avdeling, Ullevål universitetssykehus, 0407 Oslo. j.n.bruun@ioks.uio.no
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active; D019317:Evidence-Based Medicine; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000635:transmission*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019259:Lamivudine / Q000008:administration & dosage; D019829:Nevirapine / Q000008:administration & dosage; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000821:virology*; D016032:Randomized Controlled Trials as Topic; D015215:Zidovudine / Q000008:administration & dosage
D019380:Anti-HIV Agents; D019259:Lamivudine; D015215:Zidovudine; D019829:Nevirapine